Industry / Singapore
Pharmaceutical Market Aligns With Efficient Healthcare Sector
February 2011 | Industry Trend AnalysisBMI View: Singapore has a low risk pharmaceutical market. Despite having an economy that is highly dependent on exports (demand for which is inherently volatile), the country is committed to the continuous provision of quality healthcare, which contributes to a productive and harmonious society. However, returns on offer for drugmakers and medical device manufacturers will never be significant, primarily due to the city-state's small population and stringent price
To read the full article, please choose one of the following options:
Subcribers please log in




